Coloplast will not exit Russia, says CEO
Around 70 employees in Russia will continue working, as the medtech firm keeps operations running in the country – out of concern for people with intimate health needs, says CEO Kristian Villumsen.
by marketwire, translated by daniel pedersen
At present, Coloplast has no plans to exit Russia, where the medtech firm employs around 70 people. In an interview with MarketWire, CEO Kristian Villumsen explains this, saying the firm is focused on helping people with intimate health needs in the country.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Coloplast downgrades organic growth guidance
For subscribers
